

2019 nCoV Test Kit Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
In 2019, the nCoV Test Kit market experienced significant growth driven by rising demand for rapid diagnostics amid emerging infectious diseases. The market was valued at approximately $500 million, reflecting increasing investments in healthcare infrastructure and advancing technologies. The competitive landscape is evolving, with several key players expanding their product offerings.
◍ Thermo Fisher Scientific
◍ LabCorp
◍ Cepheid
◍ Hologic
◍ Danaher
◍ Roche Diagnostics
◍ BioMérieux
◍ Integrated DNA Technologies
◍ Abbott Laboratories
◍ Beijing Genomics Institute
◍ Shanghai Huirui Biotechnology
◍ Geneodx
◍ Shanghai BioGerm Medical Biotechnology
◍ Da An Gene
◍ Wondfo
◍ INNOVITA
◍ Kogenebiotech
◍ Mylab Discovery
The 2019 nCoV Test Kit Market features companies like Thermo Fisher, Roche, and Abbott, innovating in diagnostic solutions. Their advanced testing technologies enhance detection speed and accuracy, driving market growth. Notable revenues include Thermo Fisher ($24.5 billion), Roche Diagnostics ($13.4 billion), and Abbott ($34.6 billion), reflecting significant demand. Request Sample Report
Hospital
Scientific Research
Diagnostic Center
Request Sample Report
Nucleic Acid Test Kit
Antibody Test Kit
Request Sample Report
$ 4.30 Billion